(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.13%) $0.800
(-0.07%) $92.11
5 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 14.92%
@ $9.20
Issued: 15 Mar 2024 @ 15:39
Return: -32.93%
Previous signal: Mar 15 - 09:44
Previous signal:
Return: 0.77 %
Live Chart Being Loaded With Signals
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases...
Stats | |
---|---|
Today's Volume | 1.05M |
Average Volume | 2.51M |
Market Cap | 423.27M |
EPS | $0 ( 2024-02-22 ) |
Next earnings date | ( $-0.410 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.31 |
ATR14 | $0.00800 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-14 | Mossler Mark | Buy | 27 430 | Stock Option (Right to Buy) |
2024-02-14 | Mossler Mark | Buy | 18 290 | Common Stock |
2024-04-01 | Anderson Kenneth Carl | Buy | 1 389 | Common Stock |
2024-04-01 | Dubin Glenn | Buy | 1 358 | Common Stock |
2024-04-01 | Grogan Donna Roy | Buy | 1 697 | Common Stock |
INSIDER POWER |
---|
59.71 |
Last 98 transactions |
Buy: 4 435 645 | Sell: 1 001 966 |
Volume Correlation
C4 Therapeutics, Inc. Correlation
10 Most Positive Correlations | |
---|---|
QRTEA | 0.96 |
PTRA | 0.959 |
EIGR | 0.957 |
STIM | 0.957 |
ASPU | 0.955 |
SSP | 0.955 |
MDRX | 0.954 |
AKTX | 0.954 |
PRCH | 0.954 |
PSTX | 0.952 |
10 Most Negative Correlations | |
---|---|
STAY | -0.951 |
CCRC | -0.95 |
SGEN | -0.947 |
PAE | -0.944 |
EBSB | -0.94 |
PTOC | -0.931 |
DSPG | -0.93 |
PPYAU | -0.929 |
RAM | -0.92 |
LMNR | -0.918 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
C4 Therapeutics, Inc. Correlation - Currency/Commodity
C4 Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $20.76M |
Gross Profit: | $13.02M (62.72 %) |
EPS: | $-2.67 |
FY | 2023 |
Revenue: | $20.76M |
Gross Profit: | $13.02M (62.72 %) |
EPS: | $-2.67 |
FY | 2022 |
Revenue: | $31.10M |
Gross Profit: | $23.52M (75.65 %) |
EPS: | $-2.59 |
FY | 2021 |
Revenue: | $45.79M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.730 |
Financial Reports:
No articles found.
C4 Therapeutics, Inc.
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies; CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC; and earlier stage programs comprising RET degraders for the treatment of various cancers. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators